Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perinatal Tissue MSCs for C-Section Scars
NCT04034615Phase 2Withdrawn
- Sponsor
- Foshan Maternity & Child Healthcare Hospital
- Start
- May 2021
- Primary completion
- Dec 2021
- Modality
- Hydrogel Systems, Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of perinatal tissue mesenchymal stem cells in cicatrix, sponsored by Foshan Maternity & Child Healthcare Hospital. Planned start May 2021; status: withdrawn.
02
Drugs
perinatal tissue mesenchymal stem cells
03
Conditions
cicatrix
Beyond the preview
Go deeper on NCT04034615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04034615.